People | December 22, 2023
Abbott India MD Vivek Kamath resigns
His resignation would be effective from March 18, 2024
His resignation would be effective from March 18, 2024
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
Currently, Venkat is Lead – Market Access, India at Pfizer
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
The product is expected to be launched in June 2023
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
